Compound	glucostrophanthidin
NPACT-Id	NPACT00205
IUPAC	(3S,5S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17- dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
Synonyms	Strophanthyl beta-D-glucoside;5,14-Dihydroxy-3-beta-((D-glucopyranosyl)oxy)-19-oxo-5-beta-card-20(22)-enolide;5-beta-Card-20(22)-enolide, 5,14-dihydroxy-3-beta-((D-glucopyranosyl)oxy)-19-oxo-;Strophanthidin-D-glucose;Strophanthidin, 3-beta-D-glucoside;(3S,5S,10S,13R,14S,17R)-5,14-dihydroxy-13-methyl-17-(5-oxo-2H-furan-3-yl)-3-[(2R,5S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3,4,6,7,8,9,11,12,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-10-carbaldehyde
PubChem Id	22346
Class	Steroids
In-vitro anticancer activity	6 cancer cell lines
In-Vivo anticancer activity	No
Targets	No targets found
Properties	Physical Elemental Topological
InChi Key	UWXGONCJXIMJRE-OXDHUBJPSA-N
InChi	1S/C29H42O11/c1-26-6-3-18-19(29(26,37)9-5-17(26)15-10-21(32)38-13-15)4-8-28(36)11-16(2-7-27(18,28)14-31)39-25-24(35)23(34)22(33)20(12-30)40-25/h10,14,16-20,22-25,30,33-37H,2-9,11-13H2,1H3/t16-,17+,18?,19?,20?,22+,23?,24?,25+,26+,27-,28-,29-/m0/s1
SMILES	O[C@@]12C3C([C@@]4([C@](O)(CC3)C[C@@H](O[C@@H]3OC([C@@H](O)C(O)C3O)CO)CC4)C=O)CC[C@@]1([C@H](CC2)C1=CC(=O)OC1)C
SMART	[#6][C@]12CCC3C(CC[C@]4(O)C[C@H](CC[C@]34C=O)O[C@@H]3OC(CO)[C@@H](O)C(O)C3O)[C@@]1(O)CC[C@@H]2C1=CC(=O)OC1
CAS No.	6014-43-3
Structure Download
Cross Refrence in other databases
	Super Natural	-
	CTD	-
	HIT	-
	NCI-60 GI₅₀ data	-
Suppliers	NA,
Drug-Likeliness Filters	Lipinski's rule of five	No
	Ghose filter	No
	Veber filter	No
	Muegge Filter	No
Similarity Search	Human metabolite database	FDA approved drugs

NPACT

Naturally occuring Plant based Anticancerous Compound-Activity-Target DataBase

Help

FAQs

Statistics

Tool

Contact